References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Pfefferkornetal(2011)Designingglucokinaseactivatorswithreducedhypoglycemiarisk:discoveryofN,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamideasaclinicalcandidateforthetreatmentoftype2diMed.Chem.Commun.,2828PMID:
Pettersenetal(2014)Therelationshipofglucokinaseactivator-inducedhypoglycemiawitharteriopathy,neuronalnecrosis,andperipheralneuropathyinnonclinicalstudies.Toxicol.Pathol.42696PMID:24771080
Keywords:PF04937319,supplier,PF04937319,Glucokinase,partial,activators,activates,type,2,diabetes,Hexokinases,Hexokinases,TocrisBioscience